fluxd.news

Neurocrine to Buy Soleno for $2.9 Billion · fluxd.news

LIVE

Fintech– 0

Neurocrine to Buy Soleno for $2.9 Billion

Finance Yahoo·April 6, 2026 at 12:09 PM

Neurocrine Biosciences agreed to buy Soleno Therapeutics for $2.9 billion in a move intended to expand its endocrinology and rare-disease portfolio..

Original Source

Finance Yahoo — finance.yahoo.com

Related in Fintech

Amazon Reaffirms USPS Logistics Partnership
PYMNTS
Polymarket Overhauls Platform With New Stablecoin
PYMNTS
Sezzle Tools Boost Consumer Financial Habits
PYMNTS
CBDC Debate Highlights Digital Money Privacy Concerns
PYMNTS